Strong Buy
Average AnalystStrong Buy
Top AnalystVery Bearish
Stock Target AdvisorStrong Buy
Average UserUSD 18.94
+0.67 (+3.67)%
N/A
1.17M
USD 25.33(+33.76%)
Symbol | Name | Exchange | PHAT's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
Virtus LifeSci Biotech Pr.. | NYE | 2.29 % | 0.79 % | -0.26 (-0.40%) | USD0.02B |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
This stock has shown below median earnings growth in the previous 5 years compared to its sector